0000899243-20-000700.txt : 20200107
0000899243-20-000700.hdr.sgml : 20200107
20200107141229
ACCESSION NUMBER: 0000899243-20-000700
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200103
FILED AS OF DATE: 20200107
DATE AS OF CHANGE: 20200107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elsbree David B
CENTRAL INDEX KEY: 0001292650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 20512986
MAIL ADDRESS:
STREET 1: C/O ACME PACKET, INC.
STREET 2: 100 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-03
0
0001492674
T2 Biosystems, Inc.
TTOO
0001292650
Elsbree David B
101 HARTWELL AVENUE
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2020-01-03
4
S
0
5316
1.16
D
91081
D
Common Stock
10000
I
By spouse
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2019, to cover payment of tax liability incident to the vesting of restricted stock units.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.14 to $1.17. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ John Sprague, Attorney-in-Fact
2020-01-07